Terms: = Ovarian cancer AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2
4 results:
1. [High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of Leukemia Cells to the Antibiotic Mithramycin].
Vagapova ER; Lebedev TD; Tikhonova AD; Goikhman BV; Ivanenko KA; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2020; 54(3):522-528. PubMed ID: 32492016
[TBL] [Abstract] [Full Text] [Related]
2. lmo2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
Parvin S; Ramirez-Labrada A; Aumann S; Lu X; Weich N; Santiago G; Cortizas EM; Sharabi E; Zhang Y; Sanchez-Garcia I; Gentles AJ; Roberts E; Bilbao-Cortes D; Vega F; Chapman JR; Verdun RE; Lossos IS
Cancer Cell; 2019 Sep; 36(3):237-249.e6. PubMed ID: 31447348
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract] [Full Text] [Related]
4. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas.
Sutherland KD; Visvader JE; Choong DY; Sum EY; Lindeman GJ; Campbell IG
Int J Cancer; 2003 Oct; 107(1):155-8. PubMed ID: 12925972
[TBL] [Abstract] [Full Text] [Related]
